Upstream Processing

MaxCyte partners with Apeiron for siRNA immunotherapy

22-Jul-2020 By Ben Hargreaves

MaxCyte and Apeiron enter agreement for the use of engineering equipment for the development of a cell therapy.

Tesla’s ‘side project’ building RNA microfactories for CureVac

03-Jul-2020 By Ben Hargreaves

Elon Musk revealed the news on Twitter that Tesla was working with CureVac and ‘possibly others’ to produce RNA vaccines.

AZ agrees commercial manufacturing deal for COVID-19 vaccine

01-Jun-2020 By Ben Hargreaves

Oxford Biomedica signs on to produce clinical and commercial supply of AZD1222, which recently entered late-stage trials.

WuXi Biologics seals deal for first US production facility

21-May-2020 By Ben Hargreaves

WuXi Biologics signs land deal for a clinical and commercial facility located in Massachusetts.

MilliporeSigma set to build $100m facility for viral and gene therapies

23-Apr-2020 By Ben Hargreaves

The facility will be the company’s second facility in Carlsbad specifically for its BioReliance viral and gene therapy service.

Manufacturing alliance set to scale Oxford University coronavirus vaccine

20-Apr-2020 By Ben Hargreaves

Halix joins a consortium to produce Oxford University’s vaccine, after first patient enrolled to clinical trial.

BARDA awards $483m to scale production of Moderna’s COVID vaccine

17-Apr-2020 By Ben Hargreaves

With recruitment for Phase I trials complete, Moderna receives funds to expand manufacturing capacity ready for late-stage trials.

Lab discovery could allow for heparin produced by cell lines

16-Apr-2020 By Ben Hargreaves

Researchers from UC San Diego identify a critical gene in the heparin biosynthesis process, which could pave the way for future industrial production.

How is the supply chain for immunotherapies impacted by COVID-19?

15-Apr-2020 By Ben Hargreaves

COO of Dendreon explains how ‘every part’ of the supply chain for the company’s lead product has been affected by the novel coronavirus.

Symbiosis doubles footprint of UK biologics site

09-Apr-2020 By Ben Hargreaves

The CMO expands its Sterling site to add new office space, as well as expanding manufacturing space and supporting services.

Daiichi pays $225m to access gene therapy production platform

06-Apr-2020 By Ben Hargreaves

Daiichi partners with Ultragenyx to utilize its HeLa producer cell line platform for commercial-scale gene therapy production.

Avectas partners with Vycellix to speed cell therapy production

31-Mar-2020 By Ben Hargreaves

The partners will combine expertise to progress the novel RNA immunomodulator, VY-M.

ProBioGen, Immunogenesis in cell line development agreement

24-Mar-2020 By Vassia Barba

Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.

Lonza launches insect medium enabling increased AAV production

24-Mar-2020 By Vassia Barba

Designed specifically for AAVs production to support gene therapies, a medium launched by Lonza is expected to accelerate cell growth while saving developers time and costs.

Fujifilm Diosynth to create biocampus in the UK

18-Mar-2020 By Vassia Barba

Fujifilm Diosynth announced plans to build a research center in the UK to answer growing demand in services for biologics, vaccines, and gene therapies development.